Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Hemostemix Inc
V.HEM
Alternate Symbol(s):
HMTXF
Healthcare
Biotechnology
Hemostemix Inc. is a Canada-based autologous stem cell therapy company. The Company has developed, patented, and is scaling a patient’s blood-based stem cell therapeutics platform, which includes angiogenic cell precursors, neuronal cell precursors and cardiomyocyte cell precursors. The Company holds 87 patents on the derivation of three stem cell lineages from the patient’s blood, including...
angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01, its lead clinical-stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. ACP-01 is in a Phase 2 clinical trial in Canada and the United States. Its technology includes methods for collecting the synergetic cell population and manufacturing a personalized regenerative therapy that can be administered to a patient within seven days of the initial cell collection. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd. and PreCerv Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:HEM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(9)
•••
JocetooBad
X
View Profile
View Bullboard History
Comment by
JocetooBad
on Jul 07, 2022 10:16am
RE:$HMTXF delivers returns beyond imagination on the OTC
Get lost, random chatbot. Can someone turn these off?!
(36)
•••
GustheGreek
X
View Profile
View Bullboard History
Comment by
GustheGreek
on Jul 07, 2022 5:54am
RE:$HMTXF with a thunderous rally on the OTC, I’m buying all I
What a load of cr@p... pumping galore...
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project
posted May 01, 2024 9:00am by
Viva Gold Corp.
-
|
Previously unknown areas of gold mineralization were discovered with longer lengths and higher gold grades than expected. 21.3 meters at 5.1 gpt Au was drilled as an approximate 40-meter offset to the west of TG2211 (57.9-meters at 5.0 gpt Au commencing at 40-meters depth). James Hesketh, President & CEO stated, “Many geologists go their whole careers without seeing drill results like these ...read more
(8)
•••
anthonysolle
X
View Profile
View Bullboard History
Post by
anthonysolle
on Jul 06, 2022 11:20am
$HMTXF delivers returns beyond imagination on the OTC
$HMTXF OTC’s most wanted stock is running effortlessly on the index and is likely to blow-up in huge numbers real soon, it is the most apt to investment today, shares trading at $0.1999
...more
(7)
•••
jackmallick30
X
View Profile
View Bullboard History
Post by
jackmallick30
on Jul 06, 2022 11:07am
$HMTXF with a thunderous rally on the OTC, I’m buying all I
$HMTXF with a momentous rise in the market twice in a row and is treading ahead with the an unequaled momentum, the stocks are trading at $0.1999. $AABB $AABVF $PQEFF $AMLH $AAGC $BASA
...more
(7)
•••
TRADERCONNECTS
X
View Profile
View Bullboard History
Post by
TRADERCONNECTS
on Jul 06, 2022 8:47am
Existing stockholder exemption of the Hemostemix supply
The providing constituting the personal non-brokered placement of fifteen Million units is merely offered to existing shareholders of the corporate, who as of the closing of business on might sixteen,
...more
(1)
•••
Tjson107
X
View Profile
View Bullboard History
Post by
Tjson107
on Jul 06, 2022 8:30am
$HEM announced integration of an wholly owned subsidiary
The business is happy to announce that PreCerv Inc. ("PreCerv") has been incorporated as a completely owned subsidiary. A worldwide field of use licence for NCP-01 and its autologous stem
...more
(17)
•••
christiano
X
View Profile
View Bullboard History
Post by
christiano
on Jul 06, 2022 8:26am
$HEM market cap high up in space
$HEM is following the footsteps of prominence in the market, and has maintained a sturdy and at the same time flexible market cap over the years, the current cap valuation of the company is $17.746M
(6)
•••
Tradeconnects
X
View Profile
View Bullboard History
Post by
Tradeconnects
on Jul 06, 2022 8:22am
Data audit efficiently executed, results came out to be auth
Hemostemix have been handed back its intellectual property consisting of all the clinical trial data of ACP-01 which was long unlawfully held by Accudata and Aspire Health Science, the data audit post
...more
(8)
•••
DanielOTC
X
View Profile
View Bullboard History
Post by
DanielOTC
on Jul 06, 2022 6:53am
Creating Personalized Regenerative Cell Therapies
Hemostemix’s technology uses a patient’s own cells to treat that patient’s disease. The cornerstone of this autologous technology is a novel cell population within the blood called the synergetic cell
...more
(9)
•••
maikaljarry
X
View Profile
View Bullboard History
Post by
maikaljarry
on Jul 04, 2022 2:08pm
$HEM announced the addition of a wholly owned subsidiary
Hemostemix recently announced the incorporation of PreCerv Inc. (A wholly owned subsidiary of Hemostemix). Hemostemix will grant PreCerv a global field of use licence for NCP-01 and its autologous
...more
(9)
•••
maikaljarry
X
View Profile
View Bullboard History
Post by
maikaljarry
on Jul 04, 2022 12:04pm
$HEM perfect patent record and universal acknowledgement
$HEM owns a total of 91 patents in 5 different categories falling under 25 jurisdictions and has also been a recipient of world economic forum technology award.
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jul 04, 2022 12:00pm
Existing shareholder exemption of the Hemostemix offer
The offering constituting the private non-brokered placement of 15 Million units is only available to existing shareholders of the company, who as of the closing of business on May 16, 2022 hold
...more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jul 04, 2022 8:24am
$HEM employs a popular financial advisor to the CEO
$HEM has been welcomed as a special financial MR. Rick Groome advisor to guide CEO Thomas Smeenk, hemostemix through classified business transactions.
(9)
•••
maikaljarry
X
View Profile
View Bullboard History
Post by
maikaljarry
on Jul 04, 2022 8:20am
$HEM reports non-brokered private placement of 15 million un
Hemostemix disclosed a non-brokered private offering of about 15 million units to shareholders, priced in the context of the market, with each unit consisting of one common share and one common share
...more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jul 04, 2022 8:16am
Data audit efficiently executed, results came out to be auth
Hemostemix have been handed back its intellectual property consisting of all the clinical trial data of ACP-01 which was long unlawfully held by Accudata and Aspire Health Science, the data audit post
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up